Background: Disparities in outcomes of adult sepsis are well described by insurance status and race and ethnicity. There is a paucity of data looking at disparities in sepsis outcomes in children.
It is estimated that 32.5 million US adults have clinical osteoarthritis (OA), with the most common sites being knee and hip. OA is associated with substantial individual and societal costs.
Background: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing.
Background: The incidence of metastatic spine disease (MSD) is increasing among cancer patients.
COVID-19, Obesity, and Structural Racism.
This study supports SDG 3 and 10 by reporting that Māori and Pacific people with type 2 diabetes have consistently poorer health outcomes than European patients, indicating the need for specific policies and interventions to better manage type 2 diabetes in these subpopulations.
This Lancet Global Health Commission advances addresses SDG 3 directly, and SDGs 1, 2, 4, 5, 8 and 10 indirectly, by comprehensively demonstrating how improving eye health by treating and preventing vision impairment and vision loss can not only advance SDG 3—improving health and wellbeing for all—but also contribute to poverty reduction, zero hunger, quality education, gender equality, and decent work and economic growth. The findings of this report frame eye health as a development issue and highlight that, with a growing ageing population globally, urgent and concerted action is needed to meet unmet eye health needs globally, including incorporating equitable eye care into countries’ universal health coverage plans.
Recent pay and hiring discrimination allegations have resulted in high-dollar settlements for Google and a hospitality management company. Developments discussed in this news article cover topics related to SDG 5 (gender equality) and SDG 10 (reduced inequalities).
This book chapter advances SDG #3 and #10 by providing therapeutic strategies that can be employed in clinical trials for AD in DS will be discussed as well as their underlying scientific rationale.
This book chapter advances SDG #3 and #10 by providing a brief history of PET imaging and the radiotracers that have had a significant impact for measuring the three signature AD-related neuropathologies related to AD and provides an overview of the research utilizing PET imaging in the DS population
